Completed PHASE1 INTERVENTIONAL 3-arm NCT03432195

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

A Phase 1, Crossover Study to Evaluate the Pharmacokinetics of Corplex™ Donepezil 10 mg Transdermal Delivery System Applied to Different Body Locations

Sponsor: Corium, Inc.

Conditions Alzheimer's Disease

Interventions Donepezil TDS

Updated 7 times since 2018 Last updated: Aug 6, 2018 Started: Jan 31, 2018 Primary completion: Jun 28, 2018 Completion: Jun 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Alzheimer's Disease and is currently completed. Corium, Inc. leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2020 — Jan 2021 [monthly]

Completed PHASE1
Sep 2018 — Nov 2020 [monthly]

Completed PHASE1

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE1
Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Corium, Inc.

Data source: Corium, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tempe, United States